SMAD3 and carcinoma: We also found mutations in SMAD3, a transcription factor belonging to the TGF‐β signaling pathway that plays a key role in many tumors, and in MCTP1 gene, whose mutations have been recently associated with acquired drug resistance in carcinomas [30, 31].